Bioforce Nanosciences Holdings annual operating income
2017
2018
2019
2022
2023
2024
2025
Bioforce Nanosciences Holdings Operating Income Growth & History (BFNH)
Bioforce Nanosciences Holdings's operating income was −$489,951 for fiscal 2025.
View full Bioforce Nanosciences Holdings company overviewBioforce Nanosciences Holdings annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$489,951 | $486 | — |
| 2024 | 2024-12-31 | −$490,437 | −$18,484 | — |
| 2023 | 2023-12-31 | −$471,953 | $13,561 | — |
| 2022 | 2022-12-31 | −$485,514 | — | — |
| 2019 | 2019-12-31 | −$46,538 | $20,202 | — |
| 2018 | 2018-12-31 | −$66,740 | −$35,479 | — |
| 2017 | 2017-12-31 | −$31,261 | — | — |
Bioforce Nanosciences Holdings quarterly operating income
Q3.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$262,330 | −$139,549 | — |
| Q1 2026 | 2026-03-31 | −$117,733 | $15,724 | — |
| Q4 2025 | 2025-12-31 | −$117,798 | — | — |
| Q3 2025 | 2025-09-30 | −$115,915 | $6,109 | — |
| Q2 2025 | 2025-06-30 | −$122,781 | −$8,341 | — |
| Q1 2025 | 2025-03-31 | −$133,457 | — | — |
| Q3 2024 | 2024-09-30 | −$122,024 | — | — |
| Q2 2024 | 2024-06-30 | −$114,440 | — | — |
| Q4 2019 | 2019-12-31 | −$20,170 | −$11,576 | — |
| Q3 2019 | 2019-09-30 | −$6,334 | $309 | — |
| Q2 2019 | 2019-06-30 | −$7,182 | $20,347 | — |
| Q1 2019 | 2019-03-31 | −$12,852 | $11,122 | — |
| Q4 2018 | 2018-12-31 | −$8,594 | — | — |
| Q3 2018 | 2018-09-30 | −$6,643 | −$4,442 | — |
| Q2 2018 | 2018-06-30 | −$27,529 | — | — |
| Q1 2018 | 2018-03-31 | −$23,974 | — | — |
| Q3 2017 | 2017-09-30 | −$2,201 | — | — |
Bioforce Nanosciences Holdings operating income trends
Between the periods ended 2017-12-31 and 2025-12-31, Bioforce Nanosciences Holdings's operating income decreased from −$31,261 to −$489,951, a change of −$458,690. The latest reported quarter, Q2 2026, shows −$262,330.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioforce Nanosciences Holdings source filings ↗